MÁDARA Botanic Niacinamide Alternative 5-in-1 Serum

MÁDARA Botanic Niacinamide Alternative 5-in-1 Serum

Marsoni

M251S

$15.00

Get it in 3 business days with 1 day shipping. Friday, May 29

MÁDARA Botanic Niacinamide Alternative 5-in-1 SerumDas exklusive MDARA Botanic Niacinamide Alternative 5 in 1 Serum sorgt im Handumdrehen fr einen strahlenden, gesunden und ebenmigen Teint. Das federleichte Serum enthlt einen innovativen Pflegekomplex aus natrlichen Inhaltsstoffen, der die Haut glttet, beruhigt, strafft und mit Feuchtigkeit versorgt. Der alternative Niacinamid Komplex nutzt die wertvollen Wirkstoffe von Braunalge, Rotalge, Rosenmyrte, Moos, Flechte, Wacholder und nordischem

Easy Shipping

Quick Dispatch:

Your MÁDARA Botanic Niacinamide Alternative 5-in-1 Serum orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your MÁDARA Botanic Niacinamide Alternative 5-in-1 Serum ships.

Need Help?
Questions about MÁDARA Botanic Niacinamide Alternative 5-in-1 Serum, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for MÁDARA Botanic Niacinamide Alternative 5-in-1 Serum in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Packaging is awful, makes a complete mess. The product itself is okay, the little rods that come with it don't slide in easily and force you to scrape the metal with them when you install it , not the greatest design. Instructions also are not the best. Also, why are the holes to hang the shelf at the bottom?? Doesn't make much sense

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on April 9, 2026